Regulation of lipid metabolism and gene expression by fenofibrate in hamsters

被引:54
作者
Guo, Q [1 ]
Wang, PR [1 ]
Milot, DP [1 ]
Ippolito, MC [1 ]
Hernandez, M [1 ]
Burton, CA [1 ]
Wright, SD [1 ]
Chao, YS [1 ]
机构
[1] Merck & Co Inc, Dept Atherosclerosis & Endocrinol, Rahway, NJ 07065 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2001年 / 1533卷 / 03期
关键词
hypolipidemia; gene regulation; hypolipidemic drug; fenofibrate; syrian hamster;
D O I
10.1016/S1388-1981(01)00156-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fenofibrate is a potent hypolipidemic agent that lowers plasma lipid levels and may thus decrease the incidence of atherosclerosis. Here we investigated the molecular mechanism of fenofibrate's hypolipidemic action by characterizing its in vivo effects on the expression of mRNAs and the activities of pivotal enzymes in cholesterol and triglyceride metabolism in the hamster. Treatment of hamsters with fenofibrate led to a dose-dependent reduction in serum cholesterol concentrations. Studies on the incorporation of [C-14]acetate and [C-14]mevalonate into cholesterol suggested that this effect occurs primarily through inhibition of cholesterol biosynthesis at steps prior to mevalonate. Fenofibrate decreased levels of hepatic enzyme activities and mRNAs for 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) synthase and HMG CoA reductase. A potential mechanism for transcriptional regulation of these enzymes is via SREBP-2 that we found to be suppressed 2-fold by fenofibrate. Fenofibrate also lowered circulatory triglyceride levels. In keeping with the effect, we observed strong suppression of fatty acid synthase, acetyl-CoA carboxylase and apolipoprotein C-III mRNA and stimulation of lipoprotein lipase and acyl-CoA oxidase mRNA in the liver of fenofibrate-treated hamsters. These observations suggest that the effect of fenofibrate on triglyceride metabolism is likely to be a result of both decreased fatty acid synthesis and increased lipoprotein lipase and acyl-CoA oxidase gene expression in the liver. Surprisingly, alterations in lipoprotein lipase, acyl-CoA oxidase, acetyl-CoA carboxylase, and apolipoprotein C-III could not be observed in hamster hepatocytes incubated with fenofibric acid in vitro. These observations raise the possibility that changes in these genes may be secondary to the metabolic alterations occurring in animals but not in cultured cells and thus that the effect of fenofibrate on these genes may be indirect. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:220 / 232
页数:13
相关论文
共 77 条
[11]   FENOFIBRATE AND LDL METABOLIC HETEROGENEITY IN HYPERCHOLESTEROLEMIA [J].
CASLAKE, MJ ;
PACKARD, CJ ;
GAW, A ;
MURRAY, E ;
GRIFFIN, BA ;
VALLANCE, BD ;
SHEPHERD, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (05) :702-711
[12]   CONTROL OF THE PEROXISOMAL BETA-OXIDATION PATHWAY BY A NOVEL FAMILY OF NUCLEAR HORMONE RECEPTORS [J].
DREYER, C ;
KREY, G ;
KELLER, H ;
GIVEL, F ;
HELFTENBEIN, G ;
WAHLI, W .
CELL, 1992, 68 (05) :879-887
[13]  
DVORNIK D, 1980, P 7 INT S 28 31 MAY, P269
[14]  
GAW A, 1991, CURR OPIN LIPIDOL, V2, P39
[15]   TISSUE SELECTIVITY OF THE CHOLESTEROL-LOWERING AGENTS LOVASTATIN, SIMVASTATIN AND PRAVASTATIN IN RATS INVIVO [J].
GERMERSHAUSEN, JI ;
HUNT, VM ;
BOSTEDOR, RG ;
BAILEY, PJ ;
KARKAS, JD ;
ALBERTS, AW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 158 (03) :667-675
[16]   EFFECT OF GEMFIBROZIL ON LIPIDS, APOPROTEINS, AND POSTHEPARIN LIPOLYTIC-ACTIVITIES IN NORMOLIPIDEMIC SUBJECTS [J].
GNASSO, A ;
LEHNER, B ;
HABERBOSCH, W ;
LEISS, O ;
VONBERGMANN, K ;
AUGUSTIN, J .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (05) :387-393
[17]   LOW-DENSITY LIPOPROTEIN PATHWAY AND ITS RELATION TO ATHEROSCLEROSIS [J].
GOLDSTEIN, JL ;
BROWN, MS .
ANNUAL REVIEW OF BIOCHEMISTRY, 1977, 46 :897-930
[18]   REGULATION OF THE MEVALONATE PATHWAY [J].
GOLDSTEIN, JL ;
BROWN, MS .
NATURE, 1990, 343 (6257) :425-430
[19]   FATTY-ACIDS ACTIVATE A CHIMERA OF THE CLOFIBRIC ACID-ACTIVATED RECEPTOR AND THE GLUCOCORTICOID RECEPTOR [J].
GOTTLICHER, M ;
WIDMARK, E ;
LI, Q ;
GUSTAFSSON, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4653-4657
[20]   Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome [J].
Grundy, SM .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :18B-25B